Elevance Health, Inc. (BIT:1ANTM)

Market Cap	56.42B
Revenue (ttm)	161.15B
Net Income (ttm)	4.56B
Shares Out	n/a
EPS (ttm)	19.91
PE Ratio	12.36
Forward PE	9.73
Dividend	6.10 (2.55%)
Ex-Dividend Date	Jun 9, 2025

Volume	n/a
Average Volume	10
Open	238.80
Previous Close	238.80
Day's Range	238.80 - 238.80
52-Week Range	238.80 - 491.00
Beta	n/a
RSI	18.38
Earnings Date	Jul 16, 2025

About Ligand Pharmaceuticals

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a...

• Founded: 2001
• Employees: 104,200
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ANTM

Financial Performance

In 2024, Elevance Health's revenue was $176.81 billion, an increase of 3.19% compared to the previous year's $171.34 billion. Earnings were $5.98 billion, a decrease of -0.12%.